United States · FDA National Drug Code directory
Bactine Max
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65197-811_ec2ae48c-3497-4a66-a88c-4838a37ad3df
- Product NDC
- 65197-811
- Form
- LIQUID
- Composition / generic term
- benzalkonium chloride and lidocaine hydrochloride
- Labeler
- WellSpring Pharmaceutical Corporation
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20180622
- Source listing expiry
- 20261231
Source-listed ingredients
- BENZALKONIUM CHLORIDE — .13 g/100mL
- LIDOCAINE HYDROCHLORIDE — 4 g/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 118 mL in 1 BOTTLE, PLASTIC (65197-811-14) · 65197-811-14
- 148 mL in 1 BOTTLE (65197-811-15) · 65197-811-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →